Novo Nordisk was overwhelmed by demand for Wegovy after it was launched in the United States in 2021 and the firm's supply constraints were exacerbated when a contract manufacturer had to temporarily suspend production over manufacturing issues.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/UfLFlYG
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Novo Nordisk hikes full-year forecast on GLP-1 drug sales
https://ift.tt/f0t3o1C
No comments:
Post a Comment